tag:blogger.com,1999:blog-7857054149675424609.post7253027100597954516..comments2024-02-24T08:58:08.581+00:00Comments on RNAi Therapeutics: PBL Grants Alnylam Non-Exclusive License to RNAi Trigger IP, Increasing Alnylam Partnering ProspectsDirk Hausseckerhttp://www.blogger.com/profile/18320439857875629714noreply@blogger.comBlogger2125tag:blogger.com,1999:blog-7857054149675424609.post-82004164290312156752012-05-29T20:44:28.234+00:002012-05-29T20:44:28.234+00:00I guess that as long as Benitec and CSIRO continue...I guess that as long as Benitec and CSIRO continue to align forces, it should not change that much. Patents seem of interest particularly for ex vivo ddRNAi Rx applications.Dirk Hausseckerhttps://www.blogger.com/profile/18320439857875629714noreply@blogger.comtag:blogger.com,1999:blog-7857054149675424609.post-60683612508595542772012-05-29T13:31:43.926+00:002012-05-29T13:31:43.926+00:00What does this mean for the RNAi IP space?
http:/...What does this mean for the RNAi IP space?<br /><br />http://finance.yahoo.com/news/csiro-granted-foundational-patents-rnai-100000408.htmlAnonymousnoreply@blogger.com